← Back to Clinical Trials
Recruiting NCT06058351

NCT06058351 ABI-aftercare in Motion: Multidisciplinary Aftercare in the Home Environment in Patients With Acquired Brain Injury

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06058351
Status Recruiting
Phase
Sponsor Majanka H. Heijenbrok-Kal, PhD
Condition Acquired Brain Injury
Study Type INTERVENTIONAL
Enrollment 60 participants
Start Date 2024-03-01
Primary Completion 2027-01-01

Trial Parameters

Condition Acquired Brain Injury
Sponsor Majanka H. Heijenbrok-Kal, PhD
Study Type INTERVENTIONAL
Phase N/A
Enrollment 60
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2024-03-01
Completion 2027-01-01
Interventions
ABI-motion program

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The goal of this implementation study is to improve aftercare for patients with ABI receiving outpatient rehabilitation. The ABI-motion program was developed to improve and active lifestyle and to prevent persistent complaints after ABI and poor HR-QoL.The main questions it aims to answer are: * Is the ABI-motion program feasible? * What are the health benefits of the ABI-motion program? Participants will receive brain education, a joint therapy session with a physical or occupational or movement therapist and a buddy from a patient support organization during outpatient rehabilitation, followed by community buddy support after discharge from outpatient rehabilitation, and follow-up by a rehabilitation physician.

Eligibility Criteria

Inclusion Criteria: * Diagnosed with ABI * Follows an outpatient rehabilitation program for ABI in Rijndam Rehabilitation Exclusion Criteria: * Having a contra-indication for participation in moderate to vigorous exercise * Life expectancy \< 1 year * Incapacitated persons

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology